Search - tctmd.com

Displaying 401 - 420 of 760

Sort: Relevancy | Date

Presentation THT 2022

Key Note Address: When Pigs Fly, How Will Drugs, Devices, and Technologies Enhance the Care of Heart Failure Patients?

Presenter: Douglas Mann

February 01, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Features

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Yael L. Maxwell

January 21, 2022

News Daily News

With First-in-Human Porcine Heart Transplant, a New Chapter Begins

Yael L. Maxwell

January 11, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

Todd Neale

December 14, 2021

News Daily News

Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF

Caitlin E. Cox

December 10, 2021

News Conference News PCR London Valves 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News PCR London Valves 2021

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Shelley Wood

November 24, 2021

News Conference News AHA 2021

Canagliflozin Improves Quality of Life in HF Patients

Michael O'Riordan

November 16, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

Presentation TCT 2021

Newer Invasive Pressure Monitoring Devices

Presenter: Liviu Klein

November 06, 2021

Presentation TCT 2021

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

November 06, 2021

Presentation TCT 2021

Overview of Devices for HF: Current and Future Prospects

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Presenter: William C. Altman

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

Presentation TCT 2021

V-Sling: Transcatheter Ventricular Repair Devices for Heart Failure Patients (Cardiac Success)

Presenter: Gregg W. Stone

November 04, 2021

Presentation TCT 2021

TCT 690: Percutaneous Treatment of Left Ventricular Assist Device Inflow Cannula Obstruction: Approaches and Pitfalls

Presenter: Benjamin Kelemen

November 04, 2021

Advertisement

Key Note Address: When Pigs Fly, How Will Drugs, Devices, and Technologies Enhance the Care of Heart Failure Patients?

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

With First-in-Human Porcine Heart Transplant, a New Chapter Begins

January 2022 News Roundup

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Canagliflozin Improves Quality of Life in HF Patients

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Newer Invasive Pressure Monitoring Devices

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Overview of Devices for HF: Current and Future Prospects

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

V-Sling: Transcatheter Ventricular Repair Devices for Heart Failure Patients (Cardiac Success)

TCT 690: Percutaneous Treatment of Left Ventricular Assist Device Inflow Cannula Obstruction: Approaches and Pitfalls

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content